EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析

◆英語タイトル:EKF Diagnostics Holdings Plc (EKF) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8013824
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:60
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イギリス
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥27,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥55,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥82,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
EKF Diagnostics Holdings Plc (EKF Diagnostics) is a medical device company which designs, develops, manufactures, and commercializes chemical reagents, and analyzers for the measurement of glucose, lactate, hematocrit, hemoglobin, and glycated hemoglobin. The company’s product portfolio comprises HbA1c analyzers, hemoglobin analyzers, glucose analyzers, lactate analyzers, rapid and sepsis testing kits, reagents, and biomarkers. These products find application in blood banks, general surgeries, pharmacies, hospitals, diabetes clinics, laboratories, and sports medicine. It offers these products throughout the world through subsidiaries, and distributors. The company operates manufacturing facilities in Russia, Poland, Germany, the UK, Ireland, and the US. EKF Diagnostics is headquartered in Cardiff, Wales, the UK.

EKF Diagnostics Holdings Plc (EKF) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
EKF Diagnostics Holdings Plc, Medical Equipment, Deal Details 12
Venture Financing 12
Selah Genomics Raises USD0.4 Million in Financing Round 12
Private Equity 13
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13
Partnerships 14
EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 14
Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 15
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 16
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 17
EKF Diagnostics Enters into Co-Development Agreement with Angle 18
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 19
EKF Diagnostics Enters Into Distribution Agreement With Alere 20
Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 21
Equity Offering 22
EKF Diagnostics Raises USD7 Million in Private Placement of Shares 22
International Brand Completes Private Placement Of Shares For US$21 Million 24
Asset Transactions 25
EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25
Acquisition 26
EKF Diagnostics Sells Selah Genomics 26
Jin Jing to Acquire EKF Diagnostics 27
EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 28
EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 29
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 30
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 31
Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33
EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 34
EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 35
EKF Diagnostics Completes Acquisition of Stanbio Lab 36
EKF Diagnostics Holdings Plc – Key Competitors 37
EKF Diagnostics Holdings Plc – Key Employees 38
EKF Diagnostics Holdings Plc – Locations And Subsidiaries 39
Head Office 39
Other Locations & Subsidiaries 39
Affiliate 40
Recent Developments 41
Financial Announcements 41
Sep 11, 2017: EKF Diagnostics Holdings: Half Yearly Report 41
Mar 20, 2017: EKF Diagnostics Holdings: Final results 42
Sep 12, 2016: EKF Diagnostics Holdings: Half-year Report 43
Jul 06, 2016: EKF Diagnostics Provides Trading update for six months ended 30 June 2016 46
Apr 12, 2016: EKF Diagnostics Holdings: Final results 47
Feb 03, 2016: EKF Diagnostics: Trading update 52
Corporate Communications 53
Jul 11, 2016: EKF Diagnostics Holdings Appoints Carl Dominic Contadini As Non-Executive Director 53
May 09, 2016: EKF Diagnostics Announces Directorate Change 54
Apr 20, 2016: EKF Diagnostics Holdings Announces Directorate Change 55
Apr 11, 2016: EKF Diagnostics: Directorate Change 56
Apr 08, 2016: EKF Diagnostics Holdings Announces Directorate Change 57
Product News 58
01/20/2016: EKF Diagnostics highlight new clinical chemistry analyzer at Arab Health 2016 58
Other Significant Developments 59
Jul 17, 2017: EKF publish new diabetes and HbA1c testing guide 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
EKF Diagnostics Holdings Plc, Medical Equipment, Key Facts, 2016 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
EKF Diagnostics Holdings Plc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
EKF Diagnostics Holdings Plc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
EKF Diagnostics Holdings Plc, Deals By Market, 2011 to YTD 2017 9
EKF Diagnostics Holdings Plc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Selah Genomics Raises USD0.4 Million in Financing Round 12
Selah Genomics Acquires Lab21, Maker Of Nanotechnology-Enabled Products 13
EKF Diagnostics Enters Into Licensing Agreement With Joslin Diabetes Center 14
Arcis Biotech Enters Into Licensing Agreement With EKF Diagnostics 15
Ortho Clinical Diagnostics and EKF Diagnostic Enter into Agreement 16
Selah Genomics, Greenville Health, DecisionQ and Becton Dickinson Enter into Agreement 17
EKF Diagnostics Enters into Co-Development Agreement with Angle 18
EKF Diagnostics Enters into Research Agreement with Massachusetts General Hospital 19
EKF Diagnostics Enters Into Distribution Agreement With Alere 20
Selah Genomics Enters Into Licensing Agreement With UNIConnect For UniFlow 21
EKF Diagnostics Raises USD7 Million in Private Placement of Shares 22
International Brand Completes Private Placement Of Shares For US$21 Million 24
EKF Diagnostics Plans to Divest POC Dx Business for USD110 Million 25
EKF Diagnostics Sells Selah Genomics 26
Jin Jing to Acquire EKF Diagnostics 27
EKF Diagnostics Completes Acquisition Of Selah Genomics For US$75 Million 28
EKF Diagnostics To Acquire DiaSpect Medical For US$34.4 Million 29
EKF Diagnostics Acquires Separation Technology, Manufacturer Of In-Vitro Diagnostics Devices, From Thermo Fisher Scientific For US$4 Million 30
EKF Diagnostics Acquires 360 Genomics, Cancer Diagnostics Company, For Up To US$14.4 Million 31
Selah Genomics Acquires EnGenCore, DNA Sequencing Company 33
EKF Diagnostics Acquires 3.62% Stake In Arcis Biotech For US$0.4 Million 34
EKF Diagnostics Sells International Brand Licensing For US$0.08 Million 35
EKF Diagnostics Completes Acquisition of Stanbio Lab 36
EKF Diagnostics Holdings Plc, Key Competitors 37
EKF Diagnostics Holdings Plc, Key Employees 38
EKF Diagnostics Holdings Plc, Other Locations 39
EKF Diagnostics Holdings Plc, Subsidiaries 39
EKF Diagnostics Holdings Plc, Affiliate 40

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ EKF Diagnostics Holdings Plc (EKF)-医療機器分野:企業M&A・提携分析(EKF Diagnostics Holdings Plc (EKF) - Medical Equipment - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆